BSEInsider Trading / SAST3d ago · 17 Aug 2026, 02:03 pm
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Malabar India Fund Ltd
Neuland Laboratories Ltd · 524558
✦ AI SummaryPledge
Malabar India Fund Ltd has disclosed selling 2,72,634 equity shares of Neuland Laboratories Ltd in the secondary market, resulting in a 2.12% stake reduction.
Analysis Scores
Earnings Impact2/10
Growth Catalyst2/10
Governance Concern2/10
Regulatory Risk2/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Neuland Laboratories Ltd - 524558 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Attachments (1)
📄pdf
Download →
E9CB3BE8_599E_41CB_813C_1B48DFD5ECD3_140311.pdf
View document text
MALABAR INDIA FUND LIMITED
6th Floor, Two Tribeca, Tribeca Central, Trianon 72261, Republic of Mauritius
Tel: + (230) 404 8800 Fax: + (230) 404 8899 Email: malabarfund@apex.mu
Aug 14, 2026
Department of Corporate Affairs
BSE Limited National Stock Exchange of India Limited
P.J Tower, Dalal Street, Exchange Plaza, C-1, Block G,
Mumbai-400001 Bandra Kurla Complex,
Bandra (E)
Mumbai 400 051
Sub: Intimation/Disclosure under SEBI (Substantial Acquisition of Shares and Takeovers)
Regulations, 2011.
Dear Sir,
With reference to the captioned subject, please find enclosed (as Annexure - 1) the disclosure
under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations,
2011 pursuant to sell of 2,72,634 equity shares of Neuland Laboratories Ltd in secondary market.
We request you to take the same on your records.
Thanking You,
For Malabar India Fund Limited
Mohinee Bhollah
Director
Encl: as above
Licensed by the Financial Services Commission of Mauritius
ANNEXURE 1
FormatfordisclosuresunderRegulation29(2)ofSEBI(SubstantialAcquisitionofSharesand
Takeovers)Regulations,2011
Part-A-Detailsofthesale
NEULANDLABORATORIESLIMITED
NameoftheTargetCompany(TC)
MalabarIndiaFundLimited
Name(s)ofthesellerandPersonsActinginConcert(PAC)
withtheseller
WhetherthesellerbelongstoPromoter/Promotergroup
BSELimited&NationalStockExchangeof
Name(s)oftheStockExchange(s)wherethesharesofTC
IndiaLimited
areListed
Number %w.r.t.total %w.r.t.total
share/voting diluted
Detailsoftheacquisitionasfollows
capital share/voting
wherever capitalofthe
applicable(*) TC(**)
Beforethesale/dilutionunderconsideration,holdingof
selleralongwithPACsof:
a) Sharescarryingvotingrights
9,21,371 7.18% 7.18%
b) Sharesinthenatureofencumbrance(pledge/lien/ Nil N.A N.A
non-disposalundertaking/others)
c) Votingrights(VR)otherwisethanbyequityshares Nil N.A N.A
d) Warrants/convertible securities/any other instrument
that entitles the acquirer to receive shares carrying Nil N.A N.A
voting rights in the TC (specify holding in each
category)
e) Total(a+b+c+d) 9,21,371 7.18% 7.18%
Detailsofsale
a) Sharescarryingvotingrightssold 2,72,634 2.12% 2.12%
b) VRssoldotherwisethanbyequityshares Nil N.A N.A
c) Warrants/convertible securities/any other instrument
Nil N.A N.A
that entitles the seller to sell shares carrying voting
rightsintheTC(specifyholdingineachcategory)sold
d) Sharesinthenatureofencumbrance(pledge/lien/
non-disposalundertaking/others)
Nil N.A N.A
e) Total(a+b+c+d) 2,72,634 2.12% 2.12%
AftertheSale/dilution,holdingofselleralongwith
PACsof:
a) Sharescarryingvotingrights 6,48,737 5.06% 5.06%
b) VRsotherwisethanbyequityshares Nil N.A N.A
c) Warrants/convertible securities/any other instrument
that entitles the acquirer to receive shares carrying Nil N.A N.A
voting rights in the TC (specify holding in each
category)afteracquisition
d) Sharesinthenatureofencumbrance(pledge/lien/
Nil N.A N.A
non-disposalundertaking/others)
e) Total(a+b+c+d) 6,48,737 5.06% 5.06%
Openmarket
Mode of sale (e.g. open market / public issue / rights issue /
preferential allotment / inter-se transfer/encumbrance, etc.)
anddilution
N.A.
Salientfeaturesofthesecuritiesacquiredincludingtimetill
redemption,ratioatwhichitcanbeconvertedintoequity
shares,etc.
Between10August2024till14Aug2026
Dateofsale/dateofreceiptofintimationofallotmentofshares
/VR/warrants/convertiblesecurities/anyotherinstrumentthat
entitlestheacquirertoreceivesharesintheTC.
Rs12,82,98,890/-consistingof1,28,29,889
Equitysharecapital/totalvotingcapitaloftheTCbeforethe
equitysharesofRs10/-each.
saidsale
Rs12,82,98,890/-consistingof1,28,29,889
Equitysharecapital/totalvotingcapitaloftheTCafterthe
equitysharesofRs10/-each.
saidsale
Rs12,82,98,890/-consistingof1,28,29,889
Totaldilutedshare/votingcapitaloftheTCafterthesaidsale.
equitysharesofRs10/-each.
Part-B***
Name of the Target Company: NEULAND LABORATORIES LIMITED
Name(s) of the seller and Whether the seller PAN of the seller
Persons Acting in Concert belongs to Promoter/ and/ or PACs
(PAC) with the seller Promoter group
Malabar India Fund Limited No AAFCM6589C
For. Malabar India Fund Limited
Mohinee Bhollah
Director / Authorised Signatory
Date: Aug 14, 2026
Place: Mauritius
Note:
(*) Total share capital/ voting capital to be taken as per the latest filing done by the company to the Stock
Exchange under Clause 35 of the listing Agreement.
(**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of
the outstanding convertible securities/warrants into equity shares of the TC.
(***) Part-B shall be disclosed to the Stock Exchanges but shall not be disseminated.
******